SCHEMBL19634248

SCHEMBL19634248

CNc1cc(F)c(SN(Cc2ccc(OC)cc2OC)c2cscn2)cc1Cl

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.36
SCN8A Q9UQD0 3/20 0.35
SCN1A P35498 2/20 0.35
NR1I2 O75469 1/20 0.35
SCN1B Q07699 1/20 0.35
SCN5A Q14524 1/20 0.35
HTR2A P28223 3/20 0.35
SLC6A4 P31645 3/20 0.35
KCNH2 Q12809 3/20 0.35
APLNR P35414 1/20 0.32
TSHR P16473 4/20 0.32
ALDH1A1 P00352 4/20 0.32
CYP1A2 P05177 3/20 0.32
CYP3A4 P08684 3/20 0.32
CYP2D6 P10635 3/20 0.32
CYP2C19 P33261 3/20 0.32
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
CLK4 Q9HAZ1 2/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19634133 0.90 HTR2A (0.38) KDM4ESCN8ASCN1ANR1I2SCN1B
SCHEMBL20256322 0.84 SCN8A (0.51) SCN8ASCN1ANR1I2SCN1BSCN5A
SCHEMBL19634333 0.81 SCN1A (0.33) KDM4ESCN8ASCN1ANR1I2SCN1B
SCHEMBL19634304 0.77 ACLY (0.35) SCN8ASCN1ANR1I2SCN1BSCN5A
SCHEMBL19634257 0.75 SCN8A (0.39) SCN8ASCN1A
SCHEMBL20256415 0.74 HTR2A (0.38) KDM4EHTR2ASLC6A4KCNH2APLNR
SCHEMBL20256934 0.74 CYP1A2 (0.38) KDM4EHTR2ASLC6A4KCNH2TSHR
SCHEMBL20256744 0.74 GAA (0.38) KDM4EHTR2ASLC6A4KCNH2TSHR
SCHEMBL19633964 0.74 MAPT (0.34) KDM4ESCN8AMEN1KMT2AMAPT
SCHEMBL20256930 0.73 CYP1A2 (0.39) KDM4ETSHRALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017201468-A1 BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2017-11-23 WO disclosed